AzTrials
AzTrials

TMJ - Oral &Maxillofacial SurgeryNCT06205667

Computer Guided Versus Conventional Arthrocentesis in Management of Internal Derangements: A Randomized Clinical Study

A study testing Computer Guided Arthrocentesis and Conventional Arthrocentesis in people with TMJ - Oral &Maxillofacial Surgery, run by Ain Shams University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to evaluate the applicability, accuracy, benefits and the efficacy of 3-dimensional, printed, patient-specific guides to direct TMJ access for arthrocentesis when performed in contrast with conventional arthrocentesis of TMJ. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
TMJ - Oral &Maxillofacial Surgery
What is being tested?
Computer Guided Arthrocentesis and Conventional Arthrocentesis
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteEgypt
Study dates
1 Jun 2021to 30 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients who complain from signs and symptoms of internal derangements and were diagnosed by the RDC/TMD as having disc displacement with/ without reduction with / without limitation associated with arthralgia or as having disc displacement with reduction associated with arthralgia in a presence or absence of joint sounds.
  • Patients who did not responded to conservative treatment for a minimum of 3 months.
  • Obtaining written informed consents signed by the patients.

Who cannot join

  • Patients suffering from any muscular disorders as myofascial pain or myofascial pain with limitations
  • If the disc was not visible in the MRI examination.
  • Patients who previously received intra-articular injection of any medication or exposed to any other TMJ invasive procedure.
  • Patients who suffer from any connective tissue diseases as rheumatoid arthritis or neurologic disorders.
  • Patients with history of major jaw trauma, bisphosphonate-derived drug use, pregnancy, alcohol or drug dependence.
  • Patients with gross mechanical restrictions or history of adhesion (fibrous or bony).
  • Patients with psychiatric disease or substance abuse or have an allergy to the substance used in the study.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ainshams university

    Cairo

Other trials in Egypt

About this study

The aim of the study is to evaluate the applicability, accuracy, benefits and the efficacy of 3-dimensional, printed, patient-specific guides to direct TMJ access for arthrocentesis when performed in contrast with conventional arthrocentesis of TMJ.

Being tested
Computer Guided Arthrocentesis, Conventional Arthrocentesis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Computer Guided ArthrocentesisProcedure or surgery

    patients are going to be injected intra-articular within the superior joint space of the affected TMJ through custom guided template planned in a manner inspired by earphone design to get support from the tragus.

  • Conventional ArthrocentesisProcedure or surgery

    patients are going to be injected intra-articular within the superior joint space of the affected TMJ using conventional method anatomical landmark determination

Study groups in NCT06205667
Study groupRoleWhat they receive
Computer Guided ArthrocentesisExperimentala study group injected intra-articularly through TMJ using a computer-guided template.
Receives: Procedure: Computer Guided Arthrocentesis
Conventional ArthrocentesisActive comparatora control group which injected intra-articular through TMJ using conventional method based on anatomical landmark determination
Receives: Procedure: Conventional Arthrocentesis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attempts number of needle puncture

    Measured: intraoperative

  2. Operation time started from first needle insertion.

    Measured: intaoperative

Secondary outcomes (2)
  1. Maximum mouth opening

    Change of mouth opening measurement using RDC/TMD

    Measured: 1week, 1, 3 and 6

  2. Pain reduction

    Pain assessment using Visual analogue Scale

    Measured: 1week, 1, 3 and 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jan 2024
  2. Study start1 Jun 2021
  3. Primary completion1 Mar 2023
  4. Study completion30 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06205667
Sponsor's protocol ID
FD-ASU-RCC.IM022204
Status last verified
Mar 2021
First submitted
4 Jan 2024
Last updated
16 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Computer Guided Arthrocentesis and Conventional Arthrocentesis in people with TMJ - Oral &Maxillofacial Surgery, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attempts number of needle puncture (time frame: intraoperative). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in